GlassScriptPhysician profile
Laura R White
NPI 1700047511
$11,806.35
in general payments reported to CMS, 2019-2025
31 companies · $1,476 in 2025
The $1,476 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,860 · 2022: $3,225 · 2023: $2,564 · 2024: $1,681 · 2025: $1,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,551 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,551.49 |
| Education | $170.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,897.87 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,213.06 | 2021-2025 | |
| Janssen Biotech, INC. | $1,153.14 | 2021-2025 | Tremfya, Stelara, Simponi Aria |
| Genzyme Corporation | $1,028.56 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $1,022.93 | 2021-2025 | Winlevi, Absorica Ld, Ilumya |
| Galderma Laboratories, L.P. | $904.69 | 2021-2025 | Nemluvio, Aklief, Oracea |
| Amgen INC. | $742.88 | 2021-2025 | Otezla, Otezla |
| Lilly USA, LLC | $664.77 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $535.76 | 2021-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $533.40 | 2022-2025 | Sotyktu |
| Ucb, INC. | $320.46 | 2021-2024 | Cimzia, Bimzelx |
| Vyne Pharmaceuticals INC. | $210.86 | 2021 | |
| Leo Pharma INC. | $198.66 | 2021-2024 | Adbry |
| Journey Medical Corporation | $188.36 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $159.19 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $157.45 | 2022-2023 | Vtama |
| Incyte Corporation | $155.00 | 2021-2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $145.17 | 2021-2025 | Cabtreo, Jublia, Arazlo |
| Allergan, INC. | $141.83 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $89.95 | 2025 | |
| Almirall LLC | $81.82 | 2023-2024 | Klisyri, Seysara |
| Pfizer INC. | $66.92 | 2021-2023 | |
| Blueprint Medicines Corporation | $34.43 | 2025 | Ayvakit |
| Kyowa Kirin, INC. | $29.71 | 2023 | Poteligeo |
| Medimetriks Pharmaceuticals, INC. | $23.11 | 2025 | Clindacin Etz, Neo-Synalar |
| Botanix Sb INC | $21.17 | 2025 | Sofdra |
| Verrica Pharmaceuticals INC. | $19.44 | 2024 | Ycanth |
| Arcutis Biotherapeutics, INC. | $17.77 | 2025 | Zoryve |
| Helsinn Therapeutics (U.S.), INC. | $16.84 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.59 | 2025 | Xifaxan |
| Paratek Pharmaceuticals, INC. | $15.56 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.